Protection of the Cyp1a2(−/−) Null Mouse against Uroporphyria and Hepatic Injury Following Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
- 1 June 2001
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 173 (2) , 89-98
- https://doi.org/10.1006/taap.2001.9167
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tardaHuman Genetics, 2000
- Uroporphyrinogen III SynthaseJournal of Biological Chemistry, 2000
- Targeted Knockout of Cyp1a1 Gene Does Not Alter Hepatic Constitutive Expression of Other Genes in the Mouse [Ah] BatteryBiochemical and Biophysical Research Communications, 2000
- Chromosomal linkage analysis of porphyria in mice induced by hexachlorobenzene-iron synergismPharmacogenetics, 1998
- Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america†Hepatology, 1998
- Porphyria Cutanea Tarda of the Toxic and Sporadic VarietiesClinics in Dermatology, 1998
- Uroporphyria induced by 5-aminolaevulinic acid alone in ahrd SWR miceBiochemical Pharmacology, 1996
- Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activityPharmacogenetics, 1995
- In vitro inhibitory effect on porphyrinogen carboxylyase of liver extracts from tcdd treated miceToxicology Letters, 1984
- Acquired Toxic Porphyria Cutanea Tarda Due to HexachlorobenzeneJAMA, 1963